Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 1 - 10 |
| Updated: | 3/23/2019 |
| Start Date: | September 2019 |
| End Date: | June 2020 |
The purpose of this proposed study is to assess effectiveness of MOHS micrographic surgery as
a form of treatment for dermatofibrosarcoma protuberans in patients who are 10 years of age
or younger through review of the patients at Mayo Clinic treated from 1988-2017, and to
explore the challenges that providers face which may prevent them performing this potentially
superior treatment. This study will provide a comparison of outcomes and recurrence rates in
pediatric patients treated by MOHS versus traditional excision.
a form of treatment for dermatofibrosarcoma protuberans in patients who are 10 years of age
or younger through review of the patients at Mayo Clinic treated from 1988-2017, and to
explore the challenges that providers face which may prevent them performing this potentially
superior treatment. This study will provide a comparison of outcomes and recurrence rates in
pediatric patients treated by MOHS versus traditional excision.
Must be 10 years of age or younger. Must have biopsy proven dermatofibrosarcoma
protuberans.
We found this trial at
1
site
200 First Street SW
Rochester, Minnesota 55905
Rochester, Minnesota 55905
507-284-2511
Phone: 507-284-0066
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
